Alex Yaroshinsky

2.4k total citations · 1 hit paper
26 papers, 1.7k citations indexed

About

Alex Yaroshinsky is a scholar working on Dermatology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Alex Yaroshinsky has authored 26 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Dermatology, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Surgery. Recurrent topics in Alex Yaroshinsky's work include Acne and Rosacea Treatments and Effects (6 papers), Nail Diseases and Treatments (5 papers) and Osteoarthritis Treatment and Mechanisms (5 papers). Alex Yaroshinsky is often cited by papers focused on Acne and Rosacea Treatments and Effects (6 papers), Nail Diseases and Treatments (5 papers) and Osteoarthritis Treatment and Mechanisms (5 papers). Alex Yaroshinsky collaborates with scholars based in United States, Canada and United Kingdom. Alex Yaroshinsky's co-authors include Barry Greenberg, Krisztina M. Zsebo, Roger J. Hajjar, Mariell Jessup, Brian E. Jaski, Daniel Pauly, Donna Mancini, Thomas P. Cappola, Howard C. Dittrich and Kim Wagner and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Alex Yaroshinsky

26 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID)

2011 548 citations Mariell Jessup, Barry Greenberg et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alex Yaroshinsky United States	16	764	707	337	335	169	26	1.7k
Robert Dennert Netherlands	14	670 0.9×	1.1k 1.6×	278 0.8×	36 0.1×	55 0.3×	31	2.0k
Mikio Hayashi Japan	19	392 0.5×	105 0.1×	202 0.6×	81 0.2×	93 0.6×	81	1.1k
Christopher Ferrante United States	11	604 0.8×	164 0.2×	140 0.4×	56 0.2×	73 0.4×	13	1.4k
Gaetano Vattemi Italy	23	845 1.1×	132 0.2×	107 0.3×	73 0.2×	38 0.2×	74	1.5k
Laurence Shen Lim Singapore	31	519 0.7×	92 0.1×	206 0.6×	122 0.4×	140 0.8×	58	3.9k
G. Piccolo Italy	27	832 1.1×	289 0.4×	160 0.5×	146 0.4×	24 0.1×	81	2.6k
Eva Becher Germany	15	243 0.3×	251 0.4×	200 0.6×	83 0.2×	34 0.2×	21	1.3k
Tamar Liron Israel	16	1.2k 1.5×	349 0.5×	232 0.7×	77 0.2×	100 0.6×	31	1.9k
Mario C. Rico United States	20	602 0.8×	216 0.3×	114 0.3×	96 0.3×	55 0.3×	42	1.3k
Meenakshi B. Bhattacharjee United States	19	662 0.9×	83 0.1×	125 0.4×	144 0.4×	62 0.4×	59	1.4k

Countries citing papers authored by Alex Yaroshinsky

Since Specialization

Citations

This map shows the geographic impact of Alex Yaroshinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Yaroshinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Yaroshinsky more than expected).

Fields of papers citing papers by Alex Yaroshinsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Yaroshinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Yaroshinsky. The network helps show where Alex Yaroshinsky may publish in the future.

Co-authorship network of co-authors of Alex Yaroshinsky

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Yaroshinsky. A scholar is included among the top collaborators of Alex Yaroshinsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Yaroshinsky. Alex Yaroshinsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Perin, Emerson C., Kenneth M. Borow, Timothy D. Henry, et al.. (2023). Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure. Journal of the American College of Cardiology. 81(9). 849–863. 51 indexed citations

Grimes, Pearl E., et al.. (2022). Histopathological Changes Induced by Malassezin: A Novel Natural Microbiome Indole for Treatment of Facial Hyperpigmentation. Journal of Drugs in Dermatology. 21(2). 141–145. 9 indexed citations

Grimes, Pearl E., et al.. (2021). A novel proof-of-concept study assessing the lightening effects and safety of malassezin for treatment of facial hyperpigmentation. Journal of the American Academy of Dermatology. 87(2). 456–458. 3 indexed citations

Horrigan, Joseph P., Mike Snape, Nikoletta Nikolenko, et al.. (2020). A Phase 2 Study of AMO-02 (Tideglusib) in Congenital and Childhood-Onset Myotonic Dystrophy Type 1 (DM1). Pediatric Neurology. 112. 84–93. 58 indexed citations

Borow, Kenneth M., Alex Yaroshinsky, Barry Greenberg, & Emerson C. Perin. (2019). Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure. Circulation Research. 125(3). 265–281. 52 indexed citations

McDaniel, David H., Jacob M. Waugh, Lily I. Jiang, et al.. (2019). Evaluation of the Antioxidant Capacity and Protective Effects of a Comprehensive Topical Antioxidant Containing Water-soluble, Enzymatic, and Lipid-soluble Antioxidants.. PubMed. 12(4). 46–53. 13 indexed citations

Glaze, Daniel G., Jeffrey L. Neul, Alan K. Percy, et al.. (2017). A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Rett Syndrome. Pediatric Neurology. 76. 37–46. 76 indexed citations

Chevrier, Anik, M. Garon, É. Quenneville, et al.. (2016). Electromechanical probe and automated indentation maps are sensitive techniques in assessing early degenerated human articular cartilage. Journal of Orthopaedic Research®. 35(4). 858–867. 41 indexed citations

Liu, Lei, Xuelin Huang, Alex Yaroshinsky, & Janice N. Cormier. (2015). Joint Frailty Models for Zero-Inflated Recurrent Events in the Presence of a Terminal Event. Biometrics. 72(1). 204–214. 31 indexed citations

10.

Chevrier, Anik, M. Garon, É. Quenneville, et al.. (2014). Non-destructive electromechanical assessment (Arthro-BST) of human articular cartilage correlates with histological scores and biomechanical properties. Osteoarthritis and Cartilage. 22(11). 1926–1935. 42 indexed citations

11.

Greenberg, Barry, Alex Yaroshinsky, Krisztina M. Zsebo, et al.. (2014). Design of a Phase 2b Trial of Intracoronary Administration of AAV1/SERCA2a in Patients With Advanced Heart Failure. JACC Heart Failure. 2(1). 84–92. 109 indexed citations

12.

Yaroshinsky, Alex, et al.. (2014). A single-blinded randomized controlled study to assess the efficacy of twice daily application of sinecatechins 15% ointment when used sequentially with cryotherapy in the treatment of external genital warts.. PubMed. 13(11). 1400–5. 12 indexed citations

13.

Zsebo, Krisztina M., Alex Yaroshinsky, J Rudy, et al.. (2013). Long-Term Effects of AAV1/SERCA2a Gene Transfer in Patients With Severe Heart Failure. Circulation Research. 114(1). 101–108. 227 indexed citations

14.

Jessup, Mariell, Barry Greenberg, Donna Mancini, et al.. (2011). Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID). Circulation. 124(3). 304–313. 548 indexed citations breakdown →

15.

Greenberg, Barry, Mariell Jessup, Krisztina M. Zsebo, Alex Yaroshinsky, & Roger J. Hajjar. (2010). CUPID 1: MYDICAR® in Patients With Advanced Heart Failure Continue to Demonstrate Improvement in Clinical Outcomes Compared to Optimal Therapy 9 Months Post-Dose. Journal of Cardiac Failure. 16(11). 911–911. 1 indexed citations

16.

Changoor, Adele, Liah Fereydoonzad, Alex Yaroshinsky, & Michael D. Buschmann. (2010). Effects of Refrigeration and Freezing on the Electromechanical and Biomechanical Properties of Articular Cartilage. Journal of Biomechanical Engineering. 132(6). 64502–64502. 84 indexed citations

17.

Hajjar, Roger J., Krisztina M. Zsebo, Lawrence I. Deckelbaum, et al.. (2008). Design of a Phase 1/2 Trial of Intracoronary Administration of AAV1/SERCA2a in Patients With Heart Failure. Journal of Cardiac Failure. 14(5). 355–367. 152 indexed citations

18.

Shalita, Alan R., et al.. (2005). The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris.. PubMed. 4(1). 48–56. 28 indexed citations

19.

James, William D., Lincoln Krochmal, & Alex Yaroshinsky. (2005). Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris. Journal of the American Academy of Dermatology. 54(1). 73–81. 52 indexed citations

20.

Yaroshinsky, Alex & William D. James. (2004). The safety and efficacy of clindamycin (1% as clindamycin phosphate and tretinoin (0.025%)] for the treatment of acne vulgaris: a combined analysis of results from six controlled safety and efficacy trials conducted in Europe. Journal of the American Academy of Dermatology. 50(3). P23–P23. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact